Replies to post #77441 on Amarantus Bioscience Holdings Inc (AMBS)

[Skeetz99]

I guess you have S/T memory loss ...forget that this deal was just signed recently.

Amarantus Seeks Candidate For PD-LID

On May 22, 2013, Amarantus entered into a letter of intent to in-license a Phase II drug candidate in L-Dopa-Induced Dyskinesia (LID) in patients with Parkinson's Disease from an undisclosed third party. Once the license is complete, Amarantus plans to initiate a Phase IIb trial within 12 months.